Protein-Prebiotic Wellbeing Study

Sponsor
Arizona State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05303753
Collaborator
FrieslandCampina (Industry)
100
1
1
10.2
9.9

Study Details

Study Description

Brief Summary

Healthy participants with self-reported GI complaints will consume the protein supplement that they normally use for recovery purposes after exercise during a 3-week baseline period, followed by a 3-week intervention period in which they maintain usage of their product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. In addition, a group of healthy participants without self-reported GI complaints will serve as a reference group by consuming the protein supplement that they normally use for recovery purposes after exercise during a 3-week period.

Condition or Disease Intervention/Treatment Phase
  • Other: fermented dairy protein with prebiotic fiber
N/A

Detailed Description

A substantial number of athletes suffer from gastro-intestinal problems, which may impair performance and/or subsequent recovery. Also, gut barrier integrity is impaired with high-intensity training. Emerging studies are showing a positive correlation between the gut microbiome and muscle function, athletic performance, body composition, and natural energy levels. This study will perform an exploratory analysis of the well-being and digestive health of well-trained athletes, and assess the potential effect of fermented dairy protein with prebiotic fiber on these parameters.

Question 1: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber affect the self-reported digestive comfort compared to a 3-week baseline period? And additionally, will the quality of life (self-reported general well-being and states of mood) change with the use of this type of product?

Question 2: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber show an alteration in gut microbiota in comparison to a 3-week baseline period, while dietary intake remains unaffected?

Question 3: How is the 3-week supplementation of a fermented dairy protein with prebiotic fiber experienced by the participants (taste and concept liking)?

Question 4: Is there a difference in baseline gut microbiota between athletes with and athletes without self-reported GI complaints.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Modifying diet by adding a fermented dairy protein with prebiotic fiberModifying diet by adding a fermented dairy protein with prebiotic fiber
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
An Exploratory Study on the Effect of Fermented Dairy Protein With Prebiotic Fiber in Athletes
Actual Study Start Date :
Jan 26, 2022
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Single group

During a 3-week baseline period, participants with self-reported GI complaints consume their own protein supplement that they use for recovery purposes after exercise, followed by a 3-week intervention period in which they maintain usage of their own product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. An additional reference group of athletes without self-reported GI complaints will also be followed during a 3-week period in which they consume their own protein supplement that they use for recovery purposes after exercise.

Other: fermented dairy protein with prebiotic fiber
During the intervention period, the participant will consume a new product and will reduce the amount of protein in their normal diet reflecting the protein content of the new product.

Outcome Measures

Primary Outcome Measures

  1. Change in self-reported digestive comfort [Baseline (day 0), after 21 days and after 42 days.]

    Gastrointestinal Symptoms Rating Scores (GSRS-score: Average of all 5 sub-scores)

  2. Change in daily self-reported digestive comfort [Study period covering day 1 to day 21 compared to day 22-42.]

    Daily variation of GI complaints (averaged itemized score 1-10)

Secondary Outcome Measures

  1. Change in self-reported general wellbeing - Physical Health [Baseline (day 0), after 21 days and after 42 days.]

    Reported as physical wellbeing (Physical Health Questionnaire, PHX - average score 1-7 based on 14 items)

  2. Change in self-reported general wellbeing - Psychological Distress [Baseline (day 0), after 21 days and after 42 days.]

    Reported as psychological distress (mental distress, K6 scale - average score 0-24).

  3. Change in participants microbiota composition of fecal samples [Baseline (day 0), after 21 days and after 42 days.]

    16s microbial profiling

  4. Change in dietary intake [Baseline (day 0), after 21 days and after 42 days.]

    24-hour dietary recalls (food group intake, energy and macro- and micronutrient)

  5. Chane in self-reported states of mood [Baseline (day 0), after 21 days and after 42 days.]

    Profile of Mood States (POMS)

Other Outcome Measures

  1. Change in food composition and diet quality [Baseline (day 0), after 21 days and after 42 days.]

    Rapid eating assessment in participants (REAP)

  2. Change in product experience [Baseline (day 0), days 22, 23, 29, 36, 43.]

    Question about product experience (taste and concept liking)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy subjects living in Arizona in the USA

  • Women/Men aged between 18-35 years

  • Serious athletes (exercise at least 3 x per week)

  • With or without GI tract issues due to sport or protein/diet intake

  • 18.5 ≤ BMI ≤ 40 kg/m2

  • No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).

  • Use of a protein supplement or sports food after at least one training per day 3 x per week

  • Willing to slightly increase their protein supplement intake during the intervention phase for 21 consecutive days

  • Stable weight during the last 4 weeks, without a focus on body weight reduction through limiting caloric intake

  • Written informed consent

Exclusion Criteria:
  • Daily use of (sport) supplements containing probiotics and/or prebiotics

  • Smoking

  • Self-reported cow's milk protein allergy

  • Clinical lactose intolerance

  • Clinical milk protein allergy

  • House dust mite allergy

  • Diagnosed GI tract disorders or diseases

  • Musculoskeletal disorders

  • Metabolic disorders (such as diabetes)

  • Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).

  • Chronic use of gastric acid-suppressing medication or anti-coagulants

  • Use of antibiotics or anti-inflammatory medication the past 2 weeks

  • Blood donation in the past 2 months

  • Pregnant/lactating women

  • Athletes should not aim to lose body weight by reducing energy intake during the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arizona State University Phoenix Arizona United States 85004

Sponsors and Collaborators

  • Arizona State University
  • FrieslandCampina

Investigators

  • Principal Investigator: Floris Wardenaar, PhD, Arizona State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Arizona State University
ClinicalTrials.gov Identifier:
NCT05303753
Other Study ID Numbers:
  • STUDY00014399
First Posted:
Mar 31, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Arizona State University

Study Results

No Results Posted as of Jun 8, 2022